Sandy Beare
About
Sandy Beare is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, Sandy Beare has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 14 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandy Beare's work include Colorectal and Anal Carcinomas (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Colorectal Cancer Surgical Treatments (7 papers). Sandy Beare is often cited by papers focused on Colorectal and Anal Carcinomas (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Colorectal Cancer Surgical Treatments (7 papers). Sandy Beare collaborates with scholars based in United Kingdom, Austria and Australia. Sandy Beare's co-authors include John Bridgewater, Harpreet Wasan, Juan W. Valle, Mark Jitlal, Takuji Okusaka, Nobumasa Mizuno, Junji Furuse, David Cunningham, Sharon Forsyth and Andre Lopes and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.
In The Last Decade
Sandy Beare
30 papers receiving 1.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sandy Beare United Kingdom | 15 | 786 | 735 | 673 | 199 | 146 | 30 | 1.4k | ||
| Kimberly Moore Dalal United States | 11 | 900 1.1× | 770 1.0× | 1.0k 1.5× | 163 0.8× | 79 0.5× | 12 | 1.5k | ||
| Alexander Rehders Germany | 15 | 608 0.8× | 570 0.8× | 596 0.9× | 44 0.2× | 150 1.0× | 57 | 1.2k | ||
| Gilles Manceau France | 22 | 881 1.1× | 1.4k 2.0× | 457 0.7× | 378 1.9× | 129 0.9× | 69 | 1.9k | ||
| Shoichi Fujii Japan | 25 | 1.1k 1.3× | 1.1k 1.6× | 755 1.1× | 73 0.4× | 49 0.3× | 101 | 1.8k | ||
| Francesca Di Fabio Italy | 18 | 421 0.5× | 791 1.1× | 742 1.1× | 118 0.6× | 101 0.7× | 64 | 1.3k | ||
| Ho‐Kyung Chun South Korea | 21 | 597 0.8× | 991 1.3× | 314 0.5× | 219 1.1× | 68 0.5× | 44 | 1.3k | ||
| Shingo Noura Japan | 27 | 1.2k 1.6× | 1.1k 1.5× | 881 1.3× | 129 0.6× | 191 1.3× | 163 | 2.1k | ||
| Valentina Ferri Spain | 22 | 688 0.9× | 674 0.9× | 623 0.9× | 47 0.2× | 78 0.5× | 84 | 1.3k | ||
| Jong Lyul Lee South Korea | 19 | 781 1.0× | 883 1.2× | 230 0.3× | 82 0.4× | 73 0.5× | 134 | 1.3k | ||
| Anna Maria Frezza Italy | 22 | 170 0.2× | 759 1.0× | 764 1.1× | 230 1.2× | 165 1.1× | 78 | 1.5k |
Countries citing papers authored by Sandy Beare
Since
Specialization
Citations
This map shows the geographic impact of Sandy Beare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandy Beare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandy Beare more than expected).
Fields of papers citing papers by Sandy Beare
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Sandy Beare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandy Beare. The network helps show where Sandy Beare may publish in the future.
Co-authorship network of co-authors of Sandy Beare
This figure shows the co-authorship network connecting the top 25 collaborators of Sandy Beare. A scholar is included among the top collaborators of Sandy Beare based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandy Beare. Sandy Beare is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Brentnall, Adam R., et al.. (2023). Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri. Clinical Trials. 20(4). 425–433.
2.
Miles, Anne, Stuart A. Taylor, Ruth Evans, et al.. (2019). Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment. European Radiology. 29(7). 3889–3900.
3.
Taylor, Stuart A., Susan Mallett, Anne Miles, et al.. (2019). Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies. Health Technology Assessment. 23(66). 1–270.
4.
Backen, Alison, Andre Lopes, Harpreet Wasan, et al.. (2018). Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. British Journal of Cancer. 119(1). 27–35.
5.
Glynne‐Jones, Rob, Marcia Hall, Andre Lopes, et al.. (2018). BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC). Heliyon. 4(9). e00804–e00804.
6.
Taylor, Stuart A., Susan Mallett, Anne Miles, et al.. (2017). Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L). BMC Cancer. 17(1). 299–299.
7.
Seddon, Beatrice, Sandra J. Strauss, Jeremy Whelan, et al.. (2017). Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. The Lancet Oncology. 18(10). 1397–1410.
8.
Gollins, Simon, Nicholas P. West, David Sebag‐Montefiore, et al.. (2017). Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. British Journal of Cancer. 117(9). 1286–1294.
9.
Glynne‐Jones, Rob, David Sebag‐Montefiore, Helen Meadows, et al.. (2017). Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial. The Lancet Oncology. 18(3). 347–356.
10.
Jamieson, David, Beatrice Seddon, Hakim‐Moulay Dehbi, et al.. (2017). Abstract 5029: Pharmacogenetics of doxorubicin, gemcitabine and docetaxel in the GeDDiS soft tissue sarcoma trial. Cancer Research. 77(13_Supplement). 5029–5029.
11.
Förster, Martin, R. Mendes, Kevin J. Harrington, et al.. (2016). ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 34(15_suppl). TPS6108–TPS6108.
12.
Valle, Juan W., Harpreet Wasan, Andre Lopes, et al.. (2015). Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial. The Lancet Oncology. 16(8). 967–978.
13.
Glynne‐Jones, Rob, Natasha Hava, Vicky Goh, et al.. (2015). Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. BMC Cancer. 15(1). 764–764.
14.
Glynne‐Jones, Rob, Latha Kadalayil, Helen Meadows, et al.. (2014). Tumour- and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial. Annals of Oncology. 25(8). 1616–1622.
15.
Harrison, Mark, Sandy Beare, John Bridgewater, et al.. (2014). Bevacizumab and combination chemotherapy in rectal cancer until surgery (BACCHUS): A phase II, multicenter, open-label, randomized study of neoadjuvant chemotherapy alone without radiation in patients with MRI-defined high-risk cancer of the rectum not threatening the circumferential margin.. Journal of Clinical Oncology. 32(15_suppl). TPS3653–TPS3653.
16.
Valle, Juan W., Junji Furuse, Mark Jitlal, et al.. (2013). Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Annals of Oncology. 25(2). 391–398.
17.
Meyer, Tim, Amy A. Kirkwood, Sy Ha, et al.. (2013). A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma. British Journal of Cancer. 108(6). 1252–1259.
18.
Mizuno, Nobumasa, Juan W. Valle, Junji Furuse, et al.. (2013). Cisplatin and gemcitabine for advanced biliary tract cancer: A meta-analysis of two randomized trials.. Journal of Clinical Oncology. 31(15_suppl). 4120–4120.
19.
Gollins, Simon, Arthur Sun Myint, Mark Saunders, et al.. (2012). Excite: A Phase II Trial of Preoperative Cetuximab, Irinotecan and Capecitabine Plus Radiotherapy (RT) In Mri-Defined Locally Advanced Rectal Cancer (LARC). Annals of Oncology. 23. ix206–ix207.
20.
O’Byrne, Kenneth J., Anne Thomas, Ricky A. Sharma, et al.. (2002). A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer. British Journal of Cancer. 87(1). 15–20.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Kimberly Moore Dalal Breakdown of academic impact, for papers by Alexander Rehders Breakdown of academic impact, for papers by Gilles Manceau Breakdown of academic impact, for papers by Shoichi Fujii Breakdown of academic impact, for papers by Francesca Di Fabio Breakdown of academic impact, for papers by Ho‐Kyung Chun Breakdown of academic impact, for papers by Shingo Noura Breakdown of academic impact, for papers by Valentina Ferri Breakdown of academic impact, for papers by Jong Lyul Lee Breakdown of academic impact, for papers by Anna Maria Frezza